期刊文献+

重组质粒hTSHR转染低分化甲状腺癌细胞株后对摄碘能力及特异性基因表达的影响 被引量:2

The effects of human TSH receptor gene transfection on iodide uptake and thyroid-specific gene expression in poorly differentiated thyroid carcinoma cell line
原文传递
导出
摘要 目的 探讨重组真核表达质粒pcDNA3.1/人TSH受体(hTSHR)体外转染TSHR表达下降的低分化滤泡状甲状腺癌细胞株后,细胞摄取放射性碘功能以及甲状腺癌相关基因mRNA表达 的变化.方法 pcDNA3.1/hTSHR转化DH5a感受态菌,进行扩增、酶切,再以核苷酸测序方法鉴定.体外转染pcDNA3.1/hTSHR,通过免疫荧光检测TSHR表达产物,井型γ计数仪检测摄碘率,相对定量实时荧光PCR验证其表达的TSHR蛋白功能和特性.采用SPSS 13.0软件,对计量资料行t检验.结果pcDNA3.1/hTSHR经PCR扩增hTSHR-cDNA片段约113 kb,Kpn Ⅰ和Xha Ⅰ双酶切:hTSHR-cDNA的片段约2.3 kb,pcDNA3.1(+)的片段约5.5 kb,均同预期片段大小相符;核苷酸测序方法鉴定测序结果与GenBank中收录的hTSHR全长序列一致,表明真核表达质粒构建正确.在hTSH刺激下,转染pcDNA3.1/hTSHR细胞与转染pcDNA3.1(+)细胞比较:(1)在甲状腺肿瘤细胞胞质、胞膜有增强的绿色荧光,(2)前者125 I摄取率是后者的2.9倍(t=28.63,P<0.01),(3)甲状腺碘摄取相关基因TSHR、钠碘转运体(NIS)、甲状腺过氧化物酶(TPO)、Tg的mRNA的表达分别升高1.74倍(t=5.959,P<0.01)、7.2倍(t=3.807,P<0.05)、2.88倍(t=4.769,P<0.01)和2.67倍(t=6.388,P<0.01).结论 pcDNA3.1/hTSHR体外转染甲状腺癌肿瘤细胞后,可有效提高碘的摄取;这可为放射性碘治疗失分化甲状腺癌提供新的实验依据. Objective To investigate the changes of iodide uptake and the expression of thyroidspecific genes in poorly differentiated follicular thyroid carcinoma (FTC) cells after transfection of human TSH receptor (hTSHR) gene in vitro. Methods The recombinant eukaryotic expression plasmid PcDNA3. 1/hTSHR-cDNA was transformed into DH5a bacterial for amplification and then the recombinant plasmid was extracted. The recombinant was identified with PCR amplifying, restriction enzyme digestion analysis and DNA sequencing. The recombinant plasmid pcDNA3.1/hTSHR was transfected into FTC-133 cell line by lipofectin methodin vitro. Immunofluorescence, iodide uptake studies and real time-PCR were applied to detect target protein expression. Statistical analysis was performed with t-test using SPSS 13. 0 software. Results Kpn Ⅰ and Xba Ⅰ restriction enzyme digestion, PCR amplifying and DNA sequencing confirmed that pcDNA3. 1/hTSHR was successfully constructed. After transfection of the recombinant plasmid pcDNA3. 1/hTSHR-cDNA and the stimulation of hTSH, the tumor cells displayed the expression of hTSHR protein at cell surface and cytoplasm. The iodine uptake in pcDNA3. 1/hTSHR transfected cells was 2. 9 times higher than that of control(pcDNA3.1(+) transfected cells) group(t = 28.63, P 〈0. 01). The expression of TSHR,NIS, TPO and Tg (mRNA levels) in pcDNA3. 1/hTSHR transfected cells were also significantly elevated by 1.74 (t =5.959, P〈0.01), 7.2 (t =3.807,P〈0.05), 2.88 (t=4.769,P〈0. 01) and 2.67 times (t=6.388,P 〈0.01) respectively compared to those of the control group. Conclusion The study demonstrates that iodide uptake may be reactivated by hTSHR receptor gene transfection in poorly differentiated FTC cell.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2011年第2期92-96,共5页 Chinese Journal of Nuclear Medicine
基金 上海市重点学科建设项目(S30203)
关键词 甲状腺肿瘤 肿瘤细胞 培养的 质粒 受体 促甲状腺激素 转染 碘放射性同位素 Thyroid neoplasms Tumor cells, cultured Plasmids Receptors, thyrotropin Transfection Iodine radioisotopes
  • 相关文献

参考文献9

  • 1Coelho SM,Carvalho DP,Vaisman M,et al.New perspectives on the treatment of differentiated thyroid cancer.Arq Bras Endocrinol Metabol,2007,51:612-624.
  • 2Weiss S J,Philp NJ,Grollman EF.Iodide transport in a continuous line of cultured cells from rat thyroid.Endocrinology,1984,114:1090-1098.
  • 3Derwahl M,Kuemmel M,Goretzki P,et al.Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor:growth inhibition by cAMP.Biochem Biophys Res Commun,1993,191:1131-1138.
  • 4Hoelting T,Duh QY,Clark OH,et al.Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth,invasion and adhesion.Langenbecks Arch Chir Suppl Kongressbd,1998,115(Suppl Ⅰ):281-284.
  • 5Parmentier M,Libert F,Maenhaut C,et al.Molecular cloning of the thyrotropin receptor.Science,1989,246:1620-1622.
  • 6Hoffmann S,Maschuw K,Hassan I,et al.Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.Endocrine,2006,30:129-138.
  • 7Park HJ,Kim JY,Park KY,et al.Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.Thyroid,2000,10:211-217.
  • 8Maenhaut C,Brabant G,Vassart G,etal.In vitro and in vivo regulation of thyrotropin receptor mRNA levels in dog and human thyroid cells.J Biol Chem,1992,267:3000-3007.
  • 9张一帆,李彪,赵龙,尤蓓,尹桂芝,贾世海,朱承谟.杆状病毒介导NIS基因放射治疗甲状腺癌的实验研究[J].中华核医学杂志,2004,24(5):264-267. 被引量:6

二级参考文献14

  • 1Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med, 2002, 29: 775-782.
  • 2Weiss SJ, Philp NJ, Grollman EF. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology, 1984, 114: 1090-1098.
  • 3Kogai T, Schultz JJ, Johnson LS, et al. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA, 2000, 97: 8519-8524.
  • 4Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide symporter. Nature, 1996, 379: 458-460.
  • 5Smanik PA, Liu Q, Furminger TL, et al. Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun, 1996, 226: 339-345.
  • 6Spitzweg C, Harrington K J, Pinke LA, et al. The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab,2001, 86: 3327-3335.
  • 7Shimura H, Haraguchi K, Myazaki A, et al. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. Endocrinology, 1997, 138: 4493-4496.
  • 8Smit JW, Shroder-van der Elst JP, Kaperien M, et al. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line. Thyroid, 2000, 10: 939-943.
  • 9Schimitt TL, Espinoza CR, Loos U. Characterization of a thyroid-specific and cyclic adenosine monophosphate-responsive enhancer far upstream from the human sodium iodide sympoter gene. Thyroid, 2002, 12: 273-279.
  • 10Hofmann C, Sandig V, Jennings G, et al. Efficient gene transfer into human hepatocytes by baculovirus vector. Proc Natl Acad Sci USA, 1995,92: 10099-10103.

共引文献5

同被引文献44

  • 1吕红彬,闫乃红,罗清礼,夏庆杰,曹桂群,张发强.促甲状腺素受体在BALB/c小鼠主要组织和器官的分布及其意义[J].解剖学杂志,2006,29(5):557-560. 被引量:5
  • 2Tomer Y, Barbesino G, Keddache M, et al. Mapping of a major sus- ceptibility locus for Graves~ disease (GD- 1 ) to chromosome 14q31. J Clin Endocrinol Metab, 1997, 82(5 ): 1645-1648.
  • 3AkamizuT, MoriyamaK, MiuraM, et ak Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs)derived from lymphocytes of patients with Graves" disease: epitope and binding study of two stimulatory TSHRAbs. Endocrinology, 1999, 140(4): 1594-1601.
  • 4Marians RC, Ng L, Blair HC, et al. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thy- rotropin receptor-null mice. Proc Natl Acad Sci USA, 2002, 99 (24): 15776-15781.
  • 5Garcia-JimOnez C, Santisteban P. TSH signalling and cancer. Arq Bras Endocrinol Metabol, 2007, 51 (5): 654-671.
  • 6Hoffmann S, Maschuw K, Hassan I, et al. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid caneer cells. Endocrine, 2006, 30( 1 ): 129-138.
  • 7Rivas M, Santisteban P. TSH-activated signaling pathways in thy-roid tumorigenesis. Mol Cell Endocrinol, 2003, 213 ( 1 ): 31-45.
  • 8Xing M, Usadel H, Cohen Y, et al. Methylation of the thyroid-stim- ulating hormone receptor gene in epithelial thyroid tumors: a mark- er of malignancy and a cause of gene silencing. Cancer Res, 2003 63(9): 2316-2321.
  • 9Yokomori N, Tawata M, Saito T, et al. Regulation of the rat thy- rotropin receptor gene by the methylation-sensitive transcription factor GA-binding protein. Mol Endocrinol, 1998,12(8): 1241-1249.
  • 10Roger PP, van Staveren WC, Coulonval K, et al. Signal transduetion in the human thyrocyte and its perversion in thyroid tumors. Mol Cell Endocrinol, 2010, 321 (1): 3-19.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部